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AbstrACt
Introduction There is little epidemiological evidence and 
knowledge about at- risk alcohol use among community- 
dwelling older adults and their chronic and acute alcohol- 
related comorbidities of interest. This systematic review 
will summarise and examine relevant studies about 
the epidemiology of at- risk alcohol use and associated 
comorbidities of interest in this population.
Methods We will search the following databases, 
without language or date restrictions, from inception to 
31 August 2019:  Embase. com, Medline Ovid SP, Pubmed 
(NOT medline[sb]), CINAHL EBSCO, PsycINFO Ovid SP, 
Central—Cochrane Library Wiley and Web of Science 
(Core Collection). Search strategies will be developed 
in collaboration with a librarian. We will use predefined 
search terms for alcoholism, epidemiology, the elderly, 
living place and comorbidities of interest, as well as terms 
related to the identification of “measurements”, “tools” 
or “instruments” for measuring harm from alcohol use. 
At- risk status will be determined by the amount of alcohol 
consumed and any comorbidities of interest associated 
with at- risk alcohol use, with the latter being documented 
separately or using an assessment tool for at- risk drinking. 
We will also examine the bibliographies of all the relevant 
articles found and search for unpublished studies. We will 
consider publications in all languages.
Ethics and dissemination No ethical approval is 
necessary. Results will be presented in national and 
international conferences on addiction and published in a 
peer- reviewed journal.
PrOsPErO registration number CRD42018099965.
IntrOduCtIOn
Alcohol consumption and misuse is a major 
substance abuse problem among community- 
dwelling older adults.1–3 Excessive alcohol 
use is a well- known health risk among elderly 
people.4 It is widely documented that older 
adults’ responses to alcohol are different 
from those of younger adults due to the phys-
iological process of ageing.5 6 The physiolog-
ical changes occurring with ageing, as well as 
differences in the activities and responsibili-
ties of older people, are used for establishing 
the criteria of alcoholism and ageing.7 8 Older 
and very old adults are more vulnerable to 
the effects of alcohol because of metabolic 
and other changes in their bodies and their 
high rate of chronic diseases.1 7
Epidemiological studies have shown 
declining alcohol use with age.4 9 However, 
the number of older adults exhibiting at- risk 
drinking is likely to increase when the age 
cohort born after 1950 (the ‘baby boomers’), 
with its heavier drinking habits, reaches old 
age.10 11 The sociodemographic and political 
changes affecting this generation, especially 
in western countries, had a great impact on 
the way people used and abused alcohol 
and psychotropic substances. Individual 
differences, like general health, physical 
or psychiatric comorbidities, drinking- age 
onset and the presence of cognitive impair-
ment can alter responses to alcohol among 
older adults.6 12 Adults reaching very old age 
strengths and limitations of this study
 ► Will provide specific, synthesised knowledge about 
the epidemiology of at- risk alcohol use among older 
and very old community- dwelling older adults.
 ► Will include a selection of associated comorbid-
ities of interest (cognitive impairment, diabetes, 
obesity, heart failure, depression, hypertension, 
insomnia, liver failure, pain and anxiety) related to 
at- risk drinking among old and very old community- 
dwelling older adults.
 ► Will report on the different definitions of at- risk 
drinking among old and very old community- 
dwelling adults in different studies and countries, 
including the quantification of their consumption.
 ► Will use inclusion criteria which impose no restric-
tions on language, study age or geographic location.
 ► Nevertheless, one potential limitation could be the 
introduction of bias due to the authors’ person-
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are more likely to suffer from cognitive decline, and the 
typical adverse effects of heavy alcohol consumption may 
worsen.13 14 Dementia resulting from alcoholism is often 
diagnosed in older adults when their evident cognitive 
and functional decline cannot be attributed to a progres-
sive neurodegenerative disorders like Alzheimer’s disease, 
or when their clinical history reveals chronic and severe 
drinking. Adults reaching very old age also undergo the 
systemic physiological and neural changes that may make 
them more susceptible to the effects of alcohol.15 16
Additionally, due to the metabolic and neurological 
changes that occur with at- risk drinking in old age, alcohol 
consumption is one of the lifestyle issues which should be 
considered in cases involving diabetic, hypertensive and 
depressive older patients.17 Many pharmacological treat-
ments have potential interactions with alcohol.18 Unfor-
tunately, the criteria for alcohol abuse and dependence 
established by the DSM or ICD (Diagnostic and Statis-
tical Manual of Mental Disorders or International Clas-
sification of Diseases) manuals are not adapted for older 
and very old adults.19 20 Bearing this in mind, physicians 
often use the at- risk, moderate and heavy drinking model 
to characterise drinking patterns more effectively.21 22 
Studies have recommended that at- risk drinking should 
be considered on a case by case basis.23 Fundamentally, 
we know that alcohol consumption in older age can 
compromise general health.5 12 Nonetheless, defining at- 
risk drinking has shown itself to be methodologically and 
conceptually challenging.24 25 Factors such as drinking 
volumes, drinking patterns, types of drinks and drink size 
have been considered in efforts to define a threshold for 
low- risk alcohol use.3 26 Limits vary between countries and 
even between regions in the same country (eg, Spain).26 27 
At- risk drinking can be defined as alcohol consumption 
beyond the limits that can lead to all- cause mortality, 
chronic conditions and acute consequences.6 15 28
The American National Institute on Alcohol Abuse and 
Alcoholism’s definition of low- risk alcohol consumption—
the lowest threshold29—has established criteria for low- 
risk drinking for adults over 65 years old. It recommends 
a pattern involving no more than one alcoholic drink 
per day and sets a standard amount of drink: one can 
(12 US fl oz or approx. 355 mL) of beer, one glass (5 
US fl oz or approx. 148 mL) of wine, a small glass (4 US 
fl oz or approx. 118 mL) of liquor or one shot (1.5 US 
fl oz or approx. 44 mL) of hard liquor. Translated into 
equivalent measures of pure alcohol, as documented in 
the literature, these equate to 0.6 fluid ounces in impe-
rial measurements and ~17 g in metric measurements.26 
Multiple features of at- risk drinking are documented in 
the literature.25 However, the USA’s low- risk drinking 
guidelines are generally in line with the risk levels 
observed in the scientific literature.2 30 Comorbidity is 
defined as the presence of more than one distinct medical 
condition in an individual. This condition can exist simul-
taneously with, but independently of, another condition, 
or it can be related.31 32 The comorbidities of interest to 
at- risk alcohol use among older adults are hypertension, 
depression, pain, liver disease, insomnia, cognitive defi-
ciency, diabetes and anxiety. Our systematic review will 
explore at- risk alcohol use because we found no reviews 
on this issue in the international literature, even though 
awareness of at- risk alcohol use among the elderly is 
rising among the general population and healthcare 
professionals. This systematic review will only examine 
at- risk alcohol (and not other substances) consumption 
because it is the substance for which we have the most 
information. The following research questions will guide 
this systematic review:
 ► What is the reported epidemiology of alcohol 
consumption, age of onset and severity of use among 
home- dwelling older adults?
 ► What are the psychiatric and somatic comorbidities 
occurring in this population?
 ► Which tools and measurements are used to docu-
ment the comorbidities associated with at- risk 
drinking?
 ► Do we have epidemiological data concerning alcohol 
use among very old adults?
 ► Is there an association between drinking volume and 
alcohol- related harm?
MEthOds
This review will be conducted following the recommen-
dations and harms- reporting checklist of the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols,33 34 the reporting proposals of the Meta- analysis 
Of Observational Studies in Epidemiology (MOOSE)35 
and the methods outlined in the Cochrane Handbook 
for Systematic Reviews of Interventions36 (online supple-
mentary 1).
Database searches and searches using other techniques 
will be completed in September 2019. Retrieved articles 
will then be screened. The entire study is expected to be 
completed by September 2020.
Inclusion criteria
Types of studies
This review will include retrospective and prospective 
epidemiological studies, cohort studies, case–control 
studies, controlled before- and- after studies, interrupted- 
time- series studies and controlled trials with inappro-
priate randomisation (quasiexperimental studies).37 38 We 
will put no language restrictions on our search for papers.
tyPEs Of PArtICIPAnts
This review will consider studies involving home- dwelling 
adults with a minimum mean age of 60 years old, as well 
as studies with participants aged 55 years old or more who 
consume at least one alcoholic drink per day. Although 
various definitions of old- age exist, we will refer to the 
United Nations cut- off considering anybody aged 60 or 
more to be an older person.39
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types of outcome measures
To highlight the epidemiology of at- risk alcohol consump-
tion and the presence of comorbidities of interest in 
home- dwelling older and very old adults, this systematic 
review protocol will use the drinking limit established 
by America’s National Institute on Alcohol Abuse and Alco-
holism.40 41 Considering at- risk drinking as a medical condi-
tion, we have chosen to search for epidemiological data 
concerning medical conditions simultaneously present 
among older adults with at- risk drinking behaviours.30 40 
We have chosen not to limit our search to medical condi-
tions cited in the Comorbidity Alcohol Risk Evaluation 
Tool.42 The following conditions are not captured by this 
tool: osteoporosis, behavioural disorders, other drug use, 
social isolation, Oto- rhino- laryngology (ORL) cancers, 
and falls and trauma.
In addition, we will cross- reference at- risk alcohol 
consumption tools involving medical conditions with 
those referenced in the CoLausPsyCoLaus study of the 
general population of Lausanne, Switzerland.43–45 This 
choice was made purposefully as, in the future, we plan 
to analyse Swiss data to compare them with data found in 
the international literature.
 ► The review’s primary outcome measures will be the:
 – Epidemiology of at- risk alcohol consumption, age 
of onset and severity of alcohol use (amount, fre-
quency and types of drinks).
 ► The review’s secondary outcome measures will be the:
 – Psychiatric and somatic comorbidities frequently 
occurring among home- dwelling older adults with 
at- risk alcohol consumption.
 – Documentation of the tools and measurements of 
comorbidities associated with at- risk drinking.
 – Presence of epidemiological data on very old 
adults’ drinking habits.
 – Associations between drinking volume and alcohol- 
related harm.
search methods for the identification of relevant studies
Electronic searches
We will search the following databases, with no language or 
date restrictions:  Embase. com, Medline Ovid SP, Pubmed 
(NOT medline[sb]), CINAHL EBSCO, PsycINFO Ovid 
SP, Central—Cochrane Library Wiley and Web of Science 
(Core Collection).
Hand and grey literature searches
We will search the reference lists of the relevant articles 
identified for unpublished studies (grey literature) and 
for experts in the field who could be contacted.
The search strategies will be adapted to each data-
base’s syntax and subject headings. Descriptor terms will 
include:
 ► Terms for alcoholism: “at- risk alcohol use”, “heavy 
drinking”, “binge drinking”, “alcohol dependence”, 
“alcohol abuse”, “Wernicke syndrome”, “Korsakoff 
dementia”, “at- risk drinking”, “alcohol consumption”, 
“alcohol dependence” and “geriatric drink*”.
 ► Epidemiological terms: “epidemiology”, “occur-
rence”, “prevalence”, “incidence” and “occasionally”.
 ► Terms for elderly: “home- dwelling older adults”, 
“elderly”, “aged”, “home- care patients”, “older adults” 
and “very old adults”.
 ► Terms for living place: “home- dwelling”, “living in 
place”, “homebound”, “primary care”, “community 
health services”, “community hospital”, “ambulatory 
care”, “outpatient clinics”, “hospital”, “ambulatory 
care facilities”, “day- care”, “primary healthcare”, 
“community health centres”, “health services for the 
aged”, “community”, “domiciliary”, “home or home- 
care or home- based”, “outpatient”, “day patient”, 
“community care”, “home- care services”, “general 
practice” and “urban population”.
 ► Terms related to the comorbidities of interest: “cogni-
tive impairment”, “diabetes”, “obesity”, “heart failure”, 
“depression”, “hypertension”, “insomnia”, “liver 
failure”, “pain”, “dementia”, “cognitive deficiency” 
and “anxiety”.
 ► Terms related to the identification of “measure-
ments”, “tools” and “instruments” for measuring the 
harm of alcohol use.
Terms related to the identification of “measurements”, 
“tools” and “instruments” for measuring the harm of 
alcohol use.
Online supplementary 2 presents the search strategy 
and equations.
data collection and analysis
Study selection
Three reviewers—ML, KE and J- PS—will independently 
screen the titles and abstracts identified in the searches to 
assess which studies meet the inclusion criteria. Disagree-
ments will be resolved through discussion or, if needed, a 
consensus will be reached after discussion with the coau-
thors (HV, AV- G).
The reviewers will then independently assess the full- 
text articles to ensure that they meet the inclusion criteria. 
Disagreements will be discussed and resolved with the 
coauthors (HV, AV- G). A flowchart of the trial selection 
process has been drawn in accordance with the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols (PRISMA) statement46 (online supplementary 
3).
Data extraction
Three authors—ML, KE and HV—will extract the data 
independently using a specially designed, standardised 
data extraction form (online supplementary 4). Discrep-
ancies will be resolved through discussion and consulta-
tion with the coauthor (AV- G).
The following information will be extracted from each 
study included: (1) study authors, year of publication 
and country where the study was conducted; (2) study 
characteristics (including setting and design, duration 
of follow- up and sample size); (3) participants’ charac-
teristics (including age, sex, social status, marital status, 
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educational status, activity, age of onset of alcohol 
consumption, level of autonomy, history of violence); (4) 
comorbidities of interest (hypertension, depression, pain, 
liver disease, insomnia, cognitive deficiency, diabetes, 
anxiety); (5) types of outcome measures.
Assessment of the risks of bias in included studies
Three reviewers—ML, KE and J- PS—will independently 
assess the risks of bias in all the retrospective and prospec-
tive epidemiological studies, cohort studies, case–control 
studies, controlled before- and- after studies, interrupted- 
time- series studies and controlled trials with inappropriate 
randomisation (quasiexperimental studies) included. 
Disagreements will be resolved through discussion and 
consultation with the coauthors (HV, AV- G).
We will use the validated Robins- I tool for assessing the 
risk of bias in non- randomised studies of interventions 
(NRSI).47 This tool covers two dimensions and seven 
domains through which bias might be introduced into 
an NRSI: (i) preintervention and at intervention (bias 
due to confounding, bias in the selection of study partic-
ipants and bias in the classification of the intervention) 
and (ii) postintervention (bias due to deviations from 
intended interventions, bias due to missing data, bias in 
the measurement of outcomes and bias in the selection 
of the reported result).47 Any disagreements in quality 
assessments will be resolved through discussion.
Our search strategy will be very careful to select orig-
inal research papers only and will try to avoid duplicates 
of published data of longitudinal studies. Additionally, 
our extraction sheet will pay special attention to longitu-
dinal cohort studies and secondary analyses of published 
results.
statistical analyses
Statistical analyses will be conducted following the recom-
mendations of the Cochrane Handbook for Systematic 
Reviews of Interventions48 and the PRISMA and MOOSE 
statements.33
For dichotomous outcomes, average intervention 
effects will be calculated as relative risks with 95% CIs, 
using a random effects model.49 For continuous data, a 
random effects model will be used to calculate weighted 
mean differences with 95% CIs. If required, we will 
calculate SD from the SE or 95% CIs presented in the 
articles. Heterogeneity will be quantified using the I2 
and χ2 tests. Funnel plots will be drawn, and Egger tests 
will be computed to explore the possibility of publi-
cation bias.50 Reasons for heterogeneity in effect esti-
mates will be sought in meta- analyses.51 To explore the 
possible determinants of heterogeneity, we will conduct 
subgroup analyses according to selected study character-
istics (eg, participants’ ages, country where the study was 
conducted, amounts of alcohol). Furthermore, sensitivity 
analyses will be conducted by: (1) excluding relatively 
small studies (with fewer than 20 participants per rando-
misation group); (2) restricting the analyses to studies of 
good quality. Data will be analysed using SPSS software 
(V.25.0) and Review Manager V.5.3.2
Patient and public involvement
No patients or members of the public were involved in 
the preparation of this protocol for a systematic review.
dIsCussIOn
At- risk alcohol use among older adults is a common 
health problem. It is under- diagnosed by primary care 
physicians, partially due to the lack of up- to- date epide-
miological data21 and partially due to the lack of relevant 
and specific diagnostic tools and instruments.24 52 We will 
propose recommendations about screening tools and 
instruments which might be particularly appropriate for 
clinicians to use when screening for alcohol misuse in 
certain contexts.
Before being able to highlight the lack of data on 
alcohol consumption among older and very old adults 
or trying to establish relevant diagnostic criteria and 
assessment methods, it is important to find out about the 
existing epidemiological data at an international level. 
It is equally important to acknowledge the difficulty in 
defining at- risk drinking at an international level and the 
methods used to extract this data.2
Demonstrating a high prevalence, frequency or inci-
dence of at- risk alcohol use among older home- dwelling 
adults could encourage physicians to use existing 
screening tests. This could be an important measure, 
considering that alcohol- related health problems reduce 
the length and quality of life.53 Recent studies, however, 
have demonstrated that elevated alcohol consumption 
cannot be evaluated solely in terms of frequency54; it is 
also necessary to know the types of drinks ingested.55
Ethics and dissemination
No ethical clearance is necessary. We expect to complete 
the study in September 2020. Results will be presented at 
national and international conferences on addiction and 
published in an international peer- reviewed journal.
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